share_log

CORRESP: CORRESP

CORRESP: CORRESP

CORRESP：信函
美股sec公告 ·  04/22 13:23
Moomoo AI 已提取核心信息
Apollomics Inc., a biopharmaceutical company, has submitted a request to the Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form F-3. The request, filed on April 22, 2024, seeks to have the Registration Statement declared effective at 5:00 p.m. Washington, D.C. time on April 24, 2024, or as soon as possible thereafter. This filing follows the initial submission of the Registration Statement on April 1, 2024. Apollomics has engaged Daniel Nussen of White & Case LLP to handle any inquiries and to be notified upon the approval of the acceleration request.
Apollomics Inc., a biopharmaceutical company, has submitted a request to the Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form F-3. The request, filed on April 22, 2024, seeks to have the Registration Statement declared effective at 5:00 p.m. Washington, D.C. time on April 24, 2024, or as soon as possible thereafter. This filing follows the initial submission of the Registration Statement on April 1, 2024. Apollomics has engaged Daniel Nussen of White & Case LLP to handle any inquiries and to be notified upon the approval of the acceleration request.
生物制药公司Apollomics Inc. 已向美国证券交易委员会（SEC）提交申请，要求加快其F-3表格注册声明的生效日期。该请求于2024年4月22日提出，旨在宣布注册声明于2024年4月24日华盛顿特区时间下午5点生效，或在此后尽快宣布生效。该文件是在2024年4月1日首次提交注册声明之后提交的。Apollomics已聘请White & Case LLP的丹尼尔·努森来处理任何查询，并在加速请求获得批准后收到通知。
生物制药公司Apollomics Inc. 已向美国证券交易委员会（SEC）提交申请，要求加快其F-3表格注册声明的生效日期。该请求于2024年4月22日提出，旨在宣布注册声明于2024年4月24日华盛顿特区时间下午5点生效，或在此后尽快宣布生效。该文件是在2024年4月1日首次提交注册声明之后提交的。Apollomics已聘请White & Case LLP的丹尼尔·努森来处理任何查询，并在加速请求获得批准后收到通知。
有用
没用

该公告为独立文件：

独立文件1

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息